<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04352790</url>
  </required_header>
  <id_info>
    <org_study_id>402/2009BO2, 522/2012BO2</org_study_id>
    <nct_id>NCT04352790</nct_id>
  </id_info>
  <brief_title>Multifactorial Risk Stratification in Stroke Patients With Cardiac Disease</brief_title>
  <official_title>Multifactorial Risk Stratification in Patients With Ischemic Stroke or Transient Ischemic Attack and Structural, Inflammatory, or Arrhythmogenic Cardiac Disease</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>University Hospital Tuebingen</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>University Hospital Tuebingen</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      Prospective registry for multifactorial risk factor assessment, enrolling consecutive
      ischemic stroke/transient ischemic attack patients with structural, inflammatory, or
      arrhythmogenic cardiac disease, who are admitted to our University Hospital.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      The prospective registry shall provide new insights into the multiple associations, and
      respective therapeutic implications of cardio-vascular risk factors and stroke. For that
      reason consecutive patients with ischemic stroke/transient ischemic attack (brain, spinal
      cord, or retinal) and structural (e.g. patent foramen ovale), septic or aseptic endocarditis
      or myocarditis, or supra-ventricular or ventricular arrhythmia, who are admitted to our
      University Hospital, are enrolled. Multifactorial assessment of risk factors is based on
      medical history, laboratory biomarkers, electrocardiogram incl. cardiac autonomic function
      analysis, and (long-term) cardiac rhythm monitoring, as well as transthoracic and
      transesophageal echocardiography. Inclusion of follow-up visits permit longitudinal and
      prognostic evaluation of routine diagnostic and therapeutic interventions for secondary
      stroke prevention (e.g. implantable loop recorders or interventional closure of patent
      foramen ovale).
    </textblock>
  </detailed_description>
  <overall_status>Active, not recruiting</overall_status>
  <start_date type="Actual">March 1, 2012</start_date>
  <completion_date type="Anticipated">December 31, 2020</completion_date>
  <primary_completion_date type="Actual">November 30, 2019</primary_completion_date>
  <study_type>Observational [Patient Registry]</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Cohort</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <target_duration>12 Months</target_duration>
  <primary_outcome>
    <measure>Rate of any stroke</measure>
    <time_frame>≥ 12 months</time_frame>
    <description>Recurrent ischemic stroke or intracranial hemorrhage during follow-up</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Rate of mortality</measure>
    <time_frame>≥ 12 months</time_frame>
    <description>Death from any cause during follow-up</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Rate of ischemic stroke</measure>
    <time_frame>≥ 12 months</time_frame>
    <description>Ischemic stroke recurrence during follow-up</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Rate of transient ischemic attack</measure>
    <time_frame>≥ 12 months</time_frame>
    <description>Transient ischemic attack recurrence during follow-up</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Rate of systemic embolism</measure>
    <time_frame>≥ 12 months</time_frame>
    <description>Systemic embolism during follow-up</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Rate of myocardial infarction</measure>
    <time_frame>≥ 12 months</time_frame>
    <description>Myocardial infarction during follow-up</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Rate of intracranial hemorrhage</measure>
    <time_frame>≥ 12 months</time_frame>
    <description>Intracranial hemorrhage during follow-up</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Rate of major Bleedings</measure>
    <time_frame>≥ 12 months</time_frame>
    <description>Major Bleedings during follow-up</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Rate of major or clinically relevant non-major bleedings</measure>
    <time_frame>≥ 12 months</time_frame>
    <description>Major or clinically relevant non-major bleedings during follow-up</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Rate of serious adverse events</measure>
    <time_frame>≥ 12 months</time_frame>
    <description>Serious adverse events during follow-up</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Rate of new-onset atrial fibrillation</measure>
    <time_frame>≥ 12 months</time_frame>
    <description>Detection of atrial fibrillation during follow-up</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>modified Rankin Score; range from 0 to 6, with '0' indicating the best outcome (i.e. no deficit), and '6' the worst outcome (i.e. death)</measure>
    <time_frame>≥ 12 months</time_frame>
    <description>modified Rankin Scale score at follow-up</description>
  </secondary_outcome>
  <enrollment type="Actual">878</enrollment>
  <condition>Stroke</condition>
  <condition>Cardiac Disease</condition>
  <eligibility>
    <study_pop>
      <textblock>
        Consecutive ischemic stroke/transient ischemic attack patients (brain, spinal crd, or
        retinal) with structural, inflammatory, or arrhythmogenic cardiac disease, who are admitted
        to our University Hospital.
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Ischemic stroke or transient ischemic attack (brain, spinal cord, or retinal)

        Exclusion Criteria:

          -  Acute intracranial hemorrhage
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <results_reference>
    <citation>Poli S, Diedler J, Härtig F, Götz N, Bauer A, Sachse T, Müller K, Müller I, Stimpfle F, Duckheim M, Steeg M, Eick C, Schreieck J, Gawaz M, Ziemann U, Zuern CS. Insertable cardiac monitors after cryptogenic stroke--a risk factor based approach to enhance the detection rate for paroxysmal atrial fibrillation. Eur J Neurol. 2016 Feb;23(2):375-81. doi: 10.1111/ene.12843. Epub 2015 Oct 16.</citation>
    <PMID>26470854</PMID>
  </results_reference>
  <verification_date>April 2020</verification_date>
  <study_first_submitted>April 15, 2020</study_first_submitted>
  <study_first_submitted_qc>April 15, 2020</study_first_submitted_qc>
  <study_first_posted type="Actual">April 20, 2020</study_first_posted>
  <last_update_submitted>April 20, 2020</last_update_submitted>
  <last_update_submitted_qc>April 20, 2020</last_update_submitted_qc>
  <last_update_posted type="Actual">April 22, 2020</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>patent foramen ovale</keyword>
  <keyword>loop recorder</keyword>
  <keyword>atrial fibrillation</keyword>
  <keyword>heart rhythm monitoring</keyword>
  <keyword>autonomic dysfunction</keyword>
  <keyword>cryptogenic stroke</keyword>
  <keyword>embolic stroke of undetermined source</keyword>
  <keyword>ESUS</keyword>
  <keyword>transient ischemic attack</keyword>
  <keyword>retinal ischemia</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Stroke</mesh_term>
    <mesh_term>Heart Diseases</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>Undecided</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

